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Abstract
Objective—Ultrasound is widely regarded as an important adjunct to antenatal care (ANC) to 
guide practice and reduce perinatal mortality. We assessed the impact of ANC ultrasound use at 
health centres in resource-limited countries.
Design—Cluster randomised trial.
Setting—Clusters within five countries (Democratic Republic of Congo, Guatemala, Kenya, 
Pakistan, and Zambia)
Methods—Clusters were randomised to standard ANC or standard care plus two ultrasounds and 
referral for complications. The study trained providers in intervention clusters to perform basic 
obstetric ultrasounds.
Main outcome measures—The primary outcome was a composite of maternal mortality, 
maternal near-miss mortality, stillbirth, and neonatal mortality.
Results—During the 24-month trial, 28 intervention and 28 control clusters had 24 263 and 23 
160 births, respectively; 78% in the intervention clusters received at least one study ultrasound; 
60% received two. The prevalence of conditions noted including twins, placenta previa, and 
abnormal lie was within expected ranges. 9% were referred for an ultrasound-diagnosed condition, 
and 71% attended the referral. The ANC (RR 1.0 95% CI 1.00, 1.01) and hospital delivery rates 
for complicated pregnancies (RR 1.03 95% CI 0.89, 1.20) did not differ between intervention and 
control clusters nor did the composite outcome (RR 1.09 95% CI 0.97, 1.23) or its individual 
components.
Conclusions—Despite availability of ultrasound at ANC in the intervention clusters, neither 
ANC nor hospital delivery for complicated pregnancies increased. The composite outcome and the 
individual components were not reduced.
Tweetable abstract
Antenatal care ultrasound did not improve a composite outcome that included maternal, fetal, and 
neonatal mortality.
Keywords
antenatal care; low-/middle-income countries; perinatal mortality; ultrasound
Introduction
Ultrasound (US) is used routinely at antenatal care (ANC) in high-income countries (HIC) to 
improve gestational age dating, reduce postdates pregnancies, and improve diagnosis of 
twins and abnormal presentations.1–4 US has also been used to evaluate fetal growth and 
amniotic fluid abnormalities as well as congenital anomalies.5,6 Despite these benefits, 
multiple systematic reviews have concluded that these potential benefits do not result in 
reduced maternal, fetal or neonatal mortality.7–10
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While reduced mortality with US use during antenatal care has not generally been shown in 
HIC, there is speculation that US could have an impact on mortality in low-/middle-income 
countries (LMIC), where rates of perinatal and maternal mortality and morbidity are high 
and the ANC coverage and quality are poor.11–13 The rationale for this potential impact 
includes US serving as an attraction for women to attend ANC earlier or more often and to 
identify high-risk pregnancies that may require advanced care.14–16 Although studies have 
explored US use in pregnancy in LMIC, no definitive studies have evaluated the impact of 
US on maternal, fetal, or neonatal mortality. However, several small studies in LMIC have 
suggested that US may increase ANC utilisation, improve referral for obstetric conditions 
discovered on US, result in more hospital deliveries, and improve gestational age dating.
16–18
 Several studies evaluating different types and lengths of training have suggested that 
lower-level obstetric providers can be trained to perform a basic obstetric US examination 
with intensive training conducted over a period of several weeks to months.19,20
Our objective was to conduct a trial to evaluate the impact of basic obstetric US at routine 
ANC visits on maternal, fetal, and neonatal mortality in LMICs.21 Because trained US 
providers are generally not available in many regions of LMIC, especially at community 
clinics where ANC is provided, and many of these regions also have a shortage of 
physicians, training of ultrasound naïve providers was a necessary component of our study.
20,22
 We evaluated whether US-naïve providers could be trained to perform basic obstetric 
US examinations to accurately determine gestational age and identify specific 
complications.21 In previously published studies, we demonstrated the high quality of the 
trainees’ US examinations.23 Based on prior studies, we had two primary hypotheses. First, 
we tested the hypothesis that in LMIC, the availability of routine US at ANC clinics would 
increase the use of ANC and hospital delivery for complicated pregnancies, and second, that 
appropriate referrals for discovered complications would reduce the composite outcome of 
maternal mortality, maternal near-miss mortality, stillbirth, and neonatal mortality.
Methods
Trial design
The First Look study was a two-arm, parallel, cluster randomised trial conducted in clusters 
in sites in rural and semi-urban areas of Zambia, Kenya, the Democratic Republic of the 
Congo (DRC), Pakistan, and Guatemala under the auspices of the Global Network for 
Women’s and Children’s Health Research (Global Network). The US training intervention 
was overseen by the University of Washington’s Department of Radiology (UW). The study 
design is described in detail elsewhere.21,23
The trial was conducted using a modification of the intent-to-treat (ITT) principle. The ITT 
population included all women in the study clusters who were residents of and delivered 
within the First Look study clusters during the site-specific analysis periods defined for this 
trial.
Goldenberg et al. Page 3
BJOG. Author manuscript; available in PMC 2019 February 26.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Participants
All pregnant women residing within study clusters were eligible for participation. A cluster 
was a defined geographic area generally served by a single health centre and its catchment 
area with about 500 births per year. At the time of the First Look study initiation, the 
government health centres in the study areas did not routinely provide US at ANC.
Each cluster, whether intervention or control, had one or more registry administrators, 
independent of the intervention, who were responsible for enrolling pregnant women in the 
Global Network Maternal Newborn Health Registry (GN MNHR) and collecting pregnancy 
and outcome data.24 The GN MNHR, which began in 2008, seeks to register women as early 
as possible during their pregnancy, and collects relevant demographic, treatment, and 
outcome data at enrolment, at delivery and at 42 days postpartum. In each cluster, every 
pregnant woman who provided consent was included in the US study regardless of whether 
she received a study US examination. Prior to the study, in each intervention cluster, 
community meetings were held to describe the study and the potential benefits of an ultra-
sound examination and to ask for community input regarding the study.
Core data
The primary outcome data for the trial, including pregnancy outcomes (stillbirth >20 weeks 
or 500 grams), neonatal death (<28 days), and maternal near-miss or mortality were 
collected by the MNHR administrators. MNHR staff also collected demographic 
information and health care for ANC and delivery for all participants. Additional process 
measures, collected by the First Look study staff, included the study ultrasound examination 
results and referrals based on the ultrasound.
Randomisation and masking
Prior to initiation of the trial, the central data coordinating centre (RTI International, 
Durham, NC) generated a random assignment of the clusters at each site to intervention and 
control treatment groups stratified by site, with additional strata within site using the most 
recent year’s perinatal mortality rates of the clusters collected through the MNH registry to 
balance on pregnancy risk. The nature of this intervention precluded masking of the study 
intervention. We were aware of the possibility of modifying the intervention through 
overattentive monitoring. To limit the risk of bias associated with unmasked reviews of study 
progress, the primary outcome data were collected by an independent team in each cluster 
associated with the MNHR.
Procedures
The intervention clusters had a pretrial training period for US-naïve healthcare practitioners 
who were identified to participate in the trial. During this period, a team consisting of UW-
sponsored sonologists or sonographers in partnership with an in-country expert from each 
site provided training in basic US obstetric examinations. The training period consisted of 2 
weeks of intensive hands-on training interwoven with didactic lectures followed by a 3-
month pilot that took place in the trainees’ antenatal clinics.23,25 During the entire training 
period, every study US examination was evaluated and scored, and specific feedback was 
provided to the trainees, a total of 3822 examinations with 26 754 images.23 Each trainee 
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completed a minimum of 50 supervised examinations during the pilot. To proceed to the 
trial, trainees were required to pass a written examination after the 2-week course and a 
practical examination by the conclusion of the training period. Four practical examinations 
were administered during the training period to monitor the trainees’ progress. Only after the 
trainee was certified to provide competent US examinations was he/she allowed to conduct 
US examinations for the trial. During the trial, a minimum of 10% of all examinations were 
evaluated for quality, and these results were used to guide continued training of the 
sonographers.
For the trial, the objective was to provide two routine US examinations at ANC, one at 16–
22 weeks to determine the number of fetuses, gestational age, amniotic fluid abnormalities, 
and major congenital anomalies and another at 32–36 weeks to document placental location, 
growth abnormalities, amniotic fluid abnormalities, and fetal mal-position. We chose those 
windows because at our network sites, most women presented for antenatal care at 20 weeks 
or later, and examinations around 20 weeks are reasonably accurate for determining 
gestational age. Examinations in the 32- to 36-week window are more accurate for 
predicting fetal position, growth restriction, and amniotic fluid abnormalities at delivery.
25–28
 The basic examination consisted of evaluation of cardiac activity, fetal position, fetal 
number, placenta position, biparietal diameter, head circumference, abdominal 
circumference, femur length, weight percentile, and amniotic fluid measurements. Hospital 
referral for specific findings such as twins, breech, placenta previa, and fetal growth 
restriction was required. Referral algorithms for each condition were created and agreed to 
by the study sonographers and representatives of the referral hospital. Sex determination was 
prohibited for the study and was not included in the training of the sonographers.
If a study sonographer left the study, a replacement sonographer was identified and a similar 
training process was conducted, with local supervision and oversight by the central team at 
the UW through a secure website.28 US training was also provided to sonographers at the 
referral hospitals to ensure consistency in addition to limited training in emergency obstetric 
and neonatal care. Building community awareness through community meetings, 
counselling patients related to the US findings, and providing an US image of the fetus to 
the mother were parts of the intervention.
The control clusters were equivalent to the intervention clusters in having the MNHR to 
enrol and track primary outcomes. Women in these clusters received standard ANC at the 
health centre without additional interventions provided.
Outcomes
The trial had primary outcomes that included both clinical and process outcomes. The 
primary composite outcome included maternal mortality, near-miss maternal mortality, 
stillbirth, and neonatal mortality. Maternal mortality was defined as any death during 
pregnancy up to 42 days post-partum. Near-miss maternal mortality was defined based on a 
modified definition of the World Health Organization (WHO) symptom list.29 Stillbirth was 
defined as any fetal death after 20-week gestation, prior to delivery. Neonatal mortality was 
defined as death of a liveborn infant up to 28 days. The process outcomes were ANC and 
hospital delivery for complicated pregnancies. ANC use was evaluated by whether the 
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woman received any ANC, four or more ANC visits, and the mean number of ANC visits. 
Complicated pregnancies were defined as those with antepartum haemorrhage, hypertensive 
disease/preeclampsia/eclampsia, breech/transverse or oblique lie, multiple birth, fetal growth 
restriction, and major congenital anomalies. These outcomes were collected at patient 
interviews and chart reviews conducted during enrolment, at delivery and 42 days 
postpartum by the GN MNHR staff. The training of US-naïve sonographers was also a 
secondary outcome, and the evaluation was previously reported.23 Finally, additional process 
measures such as US skills and the identification of conditions by US were collected only in 
the intervention clusters.
Statistical analysis
The main hypothesis was that introduction of antenatal US screening with appropriate 
referral would improve the composite outcome. The second hypothesis was that US would 
a) increase the rate of ANC utilisation and b) increase hospital deliveries for women with 
complicated pregnancies. The ANC outcome was evaluated by several measures of ANC 
utilisation. The hospital delivery outcome was evaluated using a binary measure of whether 
a complicated pregnancy was delivered in a hospital. The hypotheses were tested 
independently at a level of significance of 0.05 without controlling for multiplicity.
Both randomisation tests and model-based procedures were used to generate hypothesis tests 
as well as point and interval effect size estimates for the study outcomes. For the primary 
clinical outcome, a two-stage, cluster-level analysis proposed by Gail et al. as analogue of a 
randomisation test was used to test the hypothesis that the risk of the composite mortality 
and morbidity outcome as well as the individual components of that outcome differed by 
treatment arm.30 Point and interval estimates for these outcomes were obtained from a log-
binomial model that analysed data at the individual level with terms for treatment and 
stratification factors using generalised estimating equations (GEE) to control for correlation 
within clusters. The hypothesis that the number of ANC visits differed by treatment arm was 
tested using an extension of the proportional odds model that again used GEE to control for 
correlation within clusters. An extension of the log-binomial model using GEE was used to 
test whether the probability of the outcomes of four or more ANC visits and delivery of 
complicated pregnancies at appropriate facilities differed by treatment arm and to generate 
point and interval estimates of the relative risk of these outcomes.
All data were collected and entered at each study site; edits were reviewed at each site using 
both hand-held and secure computer systems. Data were transmitted using a secure system 
to the central data coordinating centre (RTI International) where additional data edits were 
performed; queries were resolved locally.
The trial sample size assumed a composite outcome baseline rate of at least 80 events per 
1000 pregnancies with current care in the trial clusters, based on the most recent years’ 
Global Network perinatal mortality rates.21,24 Sample size estimates assumed a target 
reduction of 25% in the composite outcome with 80% power and alpha at 0.05, and an 
intracluster correlation (ICC) of 0.005, also consistent with historic Global Network data. 
With these assumptions, 58 clusters were required to detect a 25% reduction in the 
composite outcome in the intervention compared to the control clusters.
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The Data Monitoring Committee appointed by National Institute of Child Health and 
Human Development (NICHD) reviewed the trial progress at bi-annual meetings throughout 
the trial. This trial is registered at clinicaltrials.gov (NCT01990625).
Ethical approvals
The ethics review committees of all implementing sites (Aga Khan University, Pakistan, Moi 
University, Kenya, Universidad Francisco Marroquin, Guatemala, University of Zambia, 
Zambia, and Kinshasa School of Public Health, DRC), the institutional review boards at the 
central investigators’ institutions at Columbia University, University of Washington, and RTI 
International reviewed and approved for the study. Each participant provided informed 
consent prior to study participation.
Support
This trial was funded by grants from the Bill & Melinda Gates Foundation and the Eunice 
Kennedy Shriver National Institute of Child Health. The ultrasound equipment was supplied 
by GE Healthcare. The funders had no input into the data analyses.
Results
The trial was initiated in July 2014, and enrolment was completed in May 2016 (exact dates 
varied by site). Across all sites, 49 001 women were screened for study, 48 469 consented, 
46 904 women delivered, and 46 768 mothers and 47 297 infants had the 42-day visit. The 
eligibility and lost-to-follow-up rates were similar between the intervention and control 
study groups. Figure S1 displays the screening and study eligibility. Guatemala had the 
largest number of clusters and the largest enrolment, while the DRC had the smallest 
number of clusters and the lowest enrolment. The larger number of women in the 
intervention group in Zambia is explained by one intervention cluster having a much larger 
number of deliveries than the others.
Table 1 provides characteristics of women in the intervention and control groups. No 
important differences in the characteristic between women in the intervention and control 
clusters were noted.
Of the 24 008 women who delivered in an intervention cluster, 18 640 (77.6%) received at 
least one study ultra-sound examination and of these and 12 681 (68.0%) received two or 
more examinations. Our goal was to provide US examinations in two windows, first at 16–
22 weeks and then at 32–36 weeks. Overall, first examinations were frequently performed 
after the 16- to 22-week window, while most second examinations were performed within 
the 32- to 36-week window. Figure S2 summarises the gestational age distribution of the 
study examinations.
In addition to the study US examination, based on a question asked by the MNHR after 
delivery, 95% of the intervention group and 43% of the control group received an US during 
pregnancy. The use of US among women residing in the control clusters varied substantially 
by site, representing 95% of Pakistani, 75% of Guatemalan, and <5% of the African 
participants (data not shown). An informal survey performed at each site suggested that 
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many of the nonstudy examinations occurred in hospital at the time of delivery or, if 
performed prior to delivery, were performed to learn when the baby was due or to determine 
the sex of the baby.
Findings on study US were generally within the expected ranges: multiple gestation (1.3%), 
fetal growth restriction (5.0%), oligohydramnios (0.9%), and polyhydramnios (1.1%). 
Because several findings are gestational age-dependent, we present the prevalence of 
placenta previa only on examinations at 28 weeks or more (0.3%) and abnormal lies at 32 
weeks or more (5.6%). 9.3% of women were referred at least once for an US-diagnosed 
condition; 71.1% attended the referral (data not shown).
One of our hypotheses was that the ANC rates would be higher in the intervention clusters 
compared to the control clusters (Table 2). However, the number of visits (P-value 0.78), the 
number of women with any ANC visit (RR 1.0, 95% CI 1.00, 1.01), and four or more ANC 
visits (RR 1.03, 95% CI 0.90, 1.17) were not found to differ between groups. There was a 
small increase in the percent of women with complications noted in the intervention clusters 
(25.4% vs 24.0%); however, no statistically significant differences were observed between 
the intervention and control clusters in the percent of women with complications delivering 
in a hospital with caesarean section capability (RR 1.03, 95% CI 0.89, 1.20). There were 
also no significant differences in the type of providers or in the rate of all women delivering 
in a health facility.
Table 3 presents the composite outcome (RR 1.09, 95% CI 0.97, 1.23) and the individual 
components of the composite outcome in the intervention and control clusters. There were 
no statistically significant differences in any outcome between the two groups.
Table 4 shows the composite outcomes, use of ANC, and hospital delivery for complicated 
pregnancies by site. There was not a significant difference in the composite primary 
outcome, ANC utilisation, nor hospital delivery for complicated pregnancies in the 
intervention compared to control group at any site, although the composite outcome was 
greater in the treatment clusters compared to the control clusters in the Pakistan site. None 
of the sites had a significant difference in other measures of ANC or hospital delivery 
between the groups.
Discussion
Main findings
US-naïve providers were successfully trained to conduct basic obstetric US examinations.23 
However, the routine use of US during ANC did not increase women’s use of ANC and the 
rate of hospital births for women with complications, nor did it improve the composite 
outcome of maternal, fetal and neonatal mortality, and near-miss maternal mortality, nor any 
of the individual components. These LMIC results confirm Cochrane reviews of the impact 
of routine use of US during ANC in HIC.7–10
It is important to emphasise what we did and did not study. We studied the provision of two 
routine basic US examinations during ANC with the earliest examinations at 16 weeks 
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coupled with referrals to a hospital for certain obstetric conditions. We did not study the 
benefit of first trimester examinations, either routine or for complications of miscarriages, 
abortions, or ectopic pregnancy. We also did not study the benefit of examinations performed 
at any other time in pregnancy and especially for complications at the time of labour and 
delivery. We also did not study the potential psychological benefit of US to women or 
whether US enhanced bonding with their infants. Furthermore, although some training on 
improving in-hospital obstetric and neonatal care was provided to hospitals involved in the 
study, no attempt was made to evaluate the quality of hospital care.
Strengths and limitations
The strengths of our study included its cluster randomised design, large sample size across 
multiple regions, consistent results across regions, and use of staff to collect outcome data 
who were independent of study implementation staff. We note that this is among the first if 
not the only trial in LMIC which has sufficient sample size to allow detection of a potential 
reduction in mortality or morbidity.
Because this trial was conducted in regions where perinatal research has been ongoing, it 
raised the issue of general-isability of results. We also found a substantial use of USA in 
control clusters outside of the health centres in two of our sites that may have decreased the 
impact of the intervention. However, because we did not find meaningful site differences in 
outcomes, even in regions with little US utilisation in control clusters, this is unlikely to 
explain the lack of impact.
Interpretation [in the light of other evidence]
It is important to place our study in context. Many HIC studies have assessed the value of 
routine US examinations during ANC and several Cochrane meta-analyses, one of which 
focused on routine ANC US examinations early in pregnancy and one on ANC US 
examinations later in pregnancy, all had consistent results.7,9 In those analyses, US increased 
the detection of multiple pregnancy at <24 weeks, was associated with reduction in labour 
induction for post-term pregnancy, and provided some evidence of earlier detection of fetal 
abnormalities. However, routine US did not appear to reduce adverse outcomes for babies or 
the frequency of healthcare services use by mothers and babies. One Cochrane review 
concluded that introducing routine US in resource-constrained healthcare settings could 
place a large burden on available resources, detracting from other more beneficial services.10
The introduction of various interventions without proof of efficacy in achieving an important 
clinical outcome is not uncommon either in obstetrics or in medicine in general.31 Adopting 
interventions used in high-income countries in resource-limited areas without proof of 
efficacy in those locations also occurs frequently.31 Many of these interventions are 
diagnostic in nature and while their ability to diagnose may be apparent, without the ability 
to utilise that information to improve an important outcome, introducing that test into 
practice will not be of benefit and may lead to harm. In an extensive study carried out in the 
earlier days of ultrasound, Ringa et al. concluded that the value of routine US scanning to 
improve gestational age dating or the diagnosis of intrauterine growth restriction was 
demonstrated in the randomised controlled trials. However, the results of these trials of 
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routine US use on important health effects did not give strong evidence for its use.31 Instead, 
they found that the spread of US scanning was based mainly on evaluative surveys which 
assessed its diagnostic value. We believe that only when US or any other technology can be 
shown to improve health outcomes, should it be introduced into clinical care.
Conclusions
In conclusion, this large study, one of the first in LMIC to evaluate the relationship between 
routine US examinations during ANC and important pregnancy outcomes, found no increase 
in ANC utilisation, hospital delivery for women with pregnancy complications, or reduction 
in maternal mortality, near-miss maternal mortality, stillbirth, or neonatal mortality. These 
results from LMIC confirm the prior studies of routine US use during ANC on pregnancy 
outcomes in HIC.7–10 These results do not necessarily relate to the value of US to influence 
pregnancy management during the first trimester, labour, and delivery or to its value for 
gestational age dating in research projects on pre-term birth or fetal growth restriction. We 
conclude that without improvement in the quality of care at health facilities in LMIC, there 
appears to be limited impact of routine ANC use of US alone. A systems-based approach 
focusing on the quality of facility care will likely be needed to reduce maternal mortality, 
stillbirth, and neonatal mortality in LMIC.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Table 1.
First Look study: maternal characteristics by treatment group
Intervention Control
Women, N 24 008 22 896
Maternal age (years), N (%)
<20 4306 (17.9) 4188 (18.3)
20–35 17 921 (74.7) 16 977 (74.2)
>35 1764 (7.4) 1723 (7.5)
Maternal education level, N(%)
No formal schooling/illiterate 5010 (20.9) 4836 (21.1)
No formal schooling/literate 389 (1.6) 294 (1.3)
Primary 7059 (29.4) 7235 (31.6)
Secondary 10 559 (44.0) 9486 (41.4)
University 979 (4.1) 1040 (4.5)
Parity, N (%)
0 5966 (25.3) 5988 (26.6)
1 5366 (22.8) 4960 (22.1)
2+ 12 215 (51.9) 11 532 (51.3)
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